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Abstract
Background: Cerebrospinal fluid (CSF) lactate concentrations increase after seizure
activity in many human patients independent of the underlying disease process. The
effect of seizure activity on CSF lactate concentration in dogs is unknown.
Hypothesis/Objectives: Cerebrospinal fluid lactate concentration is unaffected by
seizure activity in dogs and is more dependent on the underlying disease process
causing the seizures.
Animals: One-hundred eighteen client-owned dogs with seizure disorders.
Methods: Case series. Cerebrospinal fluid lactate concentration was determined
using a commercially available lactate monitor. Seizure semiology, time from last sei-
zure to CSF collection, number of seizures within the 72 hours preceding CSF collec-
tion, and clinical diagnosis were recorded.
Results: Dogs with focal seizures had higher CSF lactate concentrations than did
those with generalized seizures (P = .03). No differences in lactate concentrations
were found among dogs with single seizures, cluster seizures or status epilepticus
(P = .12), among dogs with CSF collection at different time points after the last sei-
zure activity (P = .39) or among dogs having different numbers of seizures within the
72 hours preceding CSF collection (P = .42). A significant difference (P = .001) was
found in CSF lactate concentrations among diagnostic groups, and dogs with inflam-
matory and neoplastic disease had higher concentrations than did dogs with idio-
pathic or unknown epilepsy.
Abbreviations: CNS, central nervous system; CSF, cerebrospinal fluid; MRI, magnetic resonance imaging; ROC, receiver-operating characteristic.
Received: 18 July 2020 Accepted: 19 October 2020
DOI: 10.1111/jvim.15953
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any
medium, provided the original work is properly cited and is not used for commercial purposes.
© 2020 The Authors. Journal of Veterinary Internal Medicine published by Wiley Periodicals LLC on behalf of American College of Veterinary Internal Medicine.
2562 J Vet Intern Med. 2020;34:2562–2570.wileyonlinelibrary.com/journal/jvim
Clinical Sciences, NC State University
Conclusions and Clinical Importance: Cerebrospinal fluid lactate concentration is
minimally affected by seizure activity in dogs and increased concentrations are more
likely associated with the underlying disease process.
K E YWORD S
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1 | INTRODUCTION
Measurement of lactate concentration in the cerebrospinal fluid (CSF)
is potentially useful as a biomarker of disease in the central nervous
system (CNS) of dogs. Several investigators have published normative
data and reference intervals for this analyte in the CSF of dogs,1-4 but
only a few reports of CSF lactate concentration in dogs with CNS dis-
ease are available.1,5-8 Cerebrospinal fluid lactate concentration in
humans is increased in a number of CNS disorders including mito-
chondrial disorders or other inborn errors of metabolism,9,10 inflam-
matory conditions,9,11,12 neoplastic disease,9 cerebrovascular disease9
and head trauma,13 and CSF lactate concentration is particularly use-
ful in discriminating bacterial from aseptic meningitis.14,15 A handheld
lactate monitor recently has been validated for quantification of lac-
tate in canine blood16 and CSF,4 and a CSF reference interval has
been established for this analyte (1.0-2.5 mmol/L).
A number of studies also suggest that CSF lactate concentration
increases in human patients after seizure activity, independent of the under-
lying cause of the seizures.9,17-20 Such increases have been described to
persist for 24 to 72 hours and confound the diagnostic utility of this analyte
in identifying underlying etiologies.9 We had not observed a consistent
increase in CSF lactate concentration in dogs after seizures.
Our objectives were to evaluate CSF lactate concentrations in dogs
with seizure disorders, to determine if these concentrations were associated
with the underlying disease process and evaluate if these concentrations
were associated temporally with the seizure activity. We hypothesized that
seizure activity would have minimal effects on CSF lactate concentration
and that this concentration would be more dependent on the underlying
disease process causing the seizures.
2 | MATERIALS AND METHODS
2.1 | Animals, sample collection, and lactate
analysis
Cerebrospinal fluid samples were collected from dogs that were
referred to the NC State Veterinary Hospital for epileptic seizures as
part of a routine diagnostic evaluation. The samples were obtained
from the cerebellomedullary cistern or lumbar subarachnoid space in a
routine manner. Most samples were analyzed immediately using a
commercially available lactate monitor (Lactate Plus, Nova Biomedical,
Waltham, Massachusetts) although some were evaluated after being
frozen at −80C, which has little effect on lactate concentration.4
2.2 | Seizure classification
Although the samples primarily were analyzed in a prospective man-
ner, medical records of dogs with CSF lactate concentration also were
retrospectively reviewed to determine diagnosis and inclusion into
the study. Dogs were included if seizures were a component of the
presenting complaint. Seizure activity was established based on owner
or referring veterinarian reports before admission or direct observa-
tion by veterinary clinicians or technicians while dogs were hospital-
ized. Additional data required for inclusion in the study were CBC,
serum biochemical analysis, CSF analysis, and a magnetic resonance
imaging (MRI) study of the brain. Seizures were classified as general-
ized, focal, or undetermined based on a review of the medical records
(seizure semiology). Dogs having both generalized and focal seizures
were placed in the generalized group for analysis purposes. Cases
also were categorized as having had a single seizure, cluster sei-
zures (>1 seizure within 24 hours) or status epilepticus
(>5 minutes of continuous seizure activity or >1 seizure without
return to baseline neurological status between events), which
was termed “seizure presentation.” The number of seizures (if clustered)
and the time from the last seizure to CSF collection also were recorded
and dogs were grouped as <24 hours, 24 to 72 hours, and > 72 hours for
comparison. Dogs having seizures within the 72 hours preceding CSF col-
lection were further categorized according to the number of observed sei-
zures in this time period as 1 to 2, 3 to 9, or >10 seizures. Dogs in status
epilepticus were included in the latter group. Cases with an incomplete
medical record were excluded but cases with incomplete information
regarding seizure semiology, seizure presentation, and seizure timing were
permitted.
2.3 | Disease categorization
Dogs were classified with idiopathic (suspected genetic, primary) epi-
lepsy if they had their first seizure between 6 months and 6 years of
age, a normal interictal neurologic examination and normal CBC,
serum biochemistry, intracranial imaging, and CSF analysis.21,22 Mild
increases in CSF protein concentration (<50 mg/dL) were permitted in
this category.23 Dogs with abnormalities on brain imaging or CSF analysis
were classified as having structural epilepsy. Those with unremarkable
diagnostic testing but falling outside of the age range determined for idio-
pathic epilepsy were classified with unknown epilepsy. For comparison
with other diagnostic groups, dogs with idiopathic and unknown epilepsy
were combined into a single cohort. Finally, dogs determined to have
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metabolic or toxic causes of their seizures were considered to have reac-
tive seizures.
Dogs with structural epilepsy were further subdivided into pre-
sumptive neoplastic, inflammatory, vascular, and miscellaneous sub-
groups. Some cases were classified using histopathological reports
after biopsy or necropsy examination. Dogs were diagnosed with pre-
sumptive neoplastic CNS disease if they had a well-defined mass
lesion on brain imaging or neoplastic cells visible on cytological evalu-
ation of the CSF. Dogs were considered to have presumptive inflam-
matory CNS disease (i.e., meningoencephalitis) if they had an increased
CSF nucleated cell count (>5 cells/μL) or brain imaging results consistent
with meningoencephalitis (multifocal or diffuse T2-weighted and fluid-
attenuated inversion recovery [FLAIR] hyperintensities with variable con-
trast enhancement). Dogs were diagnosed with a presumptive cerebro-
vascular disorder if they had acute onset of neurological signs without
subsequent progression of these signs, changes consistent with either
ischemic injury or hemorrhage on MRI (including T2* and diffusion-
weighted studies) and a CSF nucleated cell count within the reference
interval. Small diameter (<6 mm), round-ovoid, hypointense T2* lesions
(putative cerebral microbleeds), which often are seen incidentally in
dogs,24,25 were not considered sufficient for a diagnosis of a cerebrovas-
cular disorder. Additional neurological signs, improvement of signs with or
without therapeutic intervention and partial or complete resolution of
lesions on repeat brain imaging were other factors considered in assigning
cases to a diagnostic category. Dogs in the miscellaneous category included
those diagnosed with congenital malformations, neurodegenerative disor-
ders, or undefined lesions not easily categorized as described above.
2.4 | Statistical analysis
Descriptive statistics were generated for age at presentation, weight,
CSF nucleated cell count, CSF red blood cell count, and CSF protein
and lactate concentrations. D'Agostino and Pearson normality testing
TABLE 1 Physical characteristics of dogs with seizures
Diagnostic category Number of dogs Age (y) Weight (kg)
Sex
M MC F FS
Idiopathic 21 3.9 (1.1-5.9) 20.5 (5.6-46.5) 1 8 2 10
Unknown 26 7.7 (0.3-12.3) 26.9 (1.8-72.0) 2 13 2 9
Idiopathic/unknowna 47 5.9 (0.3-12.3) 21.0 (1.8-72.0) 3 21 4 19
Presumptive neoplastic 37 9.9 (5.0-13.8) 26.7 (2.8-50.4) 0 17 0 20
Presumptive inflammatory 16 5.5 (2.4-13.3) 6.3 (2.5-30.6) 1 3 1 11
Presumptive vascular 3 10.8 (8.2-12.2) 26.7 (23.1-32.6) 0 1 0 2
Miscellaneous 12 6.4 (0.1-13.4) 14.3 (1.6-45.5) 2 3 1 6
Reactive 3 12.5 (6.8-12.5) 7.4 (6.8-24.6) 0 1 0 2
All cases 118 7.4 (0.1-13.8) 20.6 (1.6-72.0) 6 46 6 60
Note: Age and weight values are expressed as median (range).
Abbreviations: F, female; FS, female spayed; M, male; MC, male castrated.
aIdiopathic/unknown is a combination of the idiopathic and unknown categories.
TABLE 2 Cerebrospinal fluid parameters in dogs with seizures
Diagnostic category
Collection site
Nucleated cell count (cells/μL) Red blood cell count (cells/μL) Protein (mg/dL)CCSF LCSF
Idiopathic 20 1 1 (0-3) 10 (0-2630) 14.8 (10.8-34.5)
Unknown 26 0 1 (0-5) 7.5 (0-8500) 17.3 (8.9-48.4)
Idiopathic/unknown 46 1 1 (0-5) 10 (0-8500) 16.0 (8.8-48.4)
Presumptive neoplastic 34 3 1 (0-10 244) 5 (0-15 000) 23.8 (12.0-146.8)
Presumptive inflammatory 13 3 92 (2-3858) 12.5 (0-5260) 79.0 (18.5-300.8)a
Presumptive vascular 3 0 1 (0-1) 0 (0-0) 24.2 (22.4-32.6)
Miscellaneous 11 1 1 (0-116) 2 (0-1183) 20.0 (9.1-2018.0)
Reactive 3 0 6 (2-44) 358 (0-518) 18.7 (13.5-101.3)
All cases 110 8 1 (0-10 244) 5 (0-15 000) 20.2 (8.8-2018)
Note: Nucleated cell count, red blood cell count, and protein values are expressed as median (range).
Abbreviations: CCSF, cerebellomedullary cistern cerebrospinal fluid; LCSF, lumbar cerebrospinal fluid.
aIn 2 samples, the quantity was not sufficient to analyze protein concentrations.
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showed that the lactate concentrations for most groups did not follow
a normal distribution and therefore nonparametric evaluations were
used to compare groups. Dogs with idiopathic and unknown epilepsy
diagnoses were combined for further analyses. Lactate concentrations
in dogs with generalized and focal seizures were compared using a
Mann-Whitney test. A Kruskal-Wallis test followed by Dunn's multi-
ple comparison test was used to compare lactate concentrations
among different seizure presentations, among dogs with different
times from last seizure to CSF collection, among dogs with different
numbers of seizures within 72 hours before CSF collection and among
diagnostic groups. A receiver-operating characteristic (ROC) analysis
was used to compare lactate concentrations in dogs with structural
epilepsy to those with idiopathic or unknown epilepsy. Spearman cor-
relation was used to examine the relationship between CSF red blood
cell counts and lactate concentrations. P values <.05 were considered
significant. All analyses were conducted using commercial software
(Prism version 8.4.2, Graphpad Software, Inc, La Jolla, California).
3 | RESULTS
A total of 118 dogs presenting with seizures were included, with a
variety of breeds represented. Descriptive statistics for age, weight
and sex of the individual diagnostic groups and the whole cohort are
shown in Table 1. One-hundred ten CSF samples (93.2%) were col-
lected from the cerebellomedullary cistern and 8 (6.8%) from the
lumbar subarachnoid space. Characteristics of the CSF analysis for
each diagnostic group are shown in Table 2. Because of limited sample
volumes, total protein concentrations were not available for 2 cases.
No correlation was found between CSF red blood cell count and CSF
lactate concentrations (P = .33, r = −0.09). Infectious disease testing
and necropsy examinations were performed in some cases, and these
results are included in a supplemental document outlining details from
dogs with structural epilepsy (Table S1).
Lactate concentrations for dogs categorized according to seizure
presentation, semiology, timing, and number of seizures within
72 hours of CSF collection are shown in Table 3. A significant differ-
ence in lactate concentrations (P = .03) was noted between dogs with
seizures noted to be generalized versus those with exclusively focal
seizures. In 8 dogs, seizure semiology was undetermined. No differ-
ence was found in lactate concentrations among dogs with single sei-
zures, cluster seizures, or status epilepticus (P = .12). In 3 dogs, the
seizure presentation could not be determined from the medical
record. Seventy-four dogs had seizures within 72 hours of CSF collec-
tion, but in 1 dog the number of seizures could not be determined. No
difference was found in lactate concentrations among dogs with CSF
collection at different time points after the last seizure activity
(P = .39, Figure 1A) or among dogs having different numbers of sei-
zures within the 72 hours preceding CSF collection (P = .42,
Figure 1B).
Lactate concentrations for dogs categorized by presumptive diag-
nosis are shown in Table 4. A significant difference (P = .001) was
TABLE 3 Cerebrospinal fluid lactate concentrations in dogs by seizure presentation, seizure semiology, time from last seizure to CSF
collection, and number of seizures within 72 hours of CSF collection
Diagnostic category Number Median lactate (range) (mmol/L) Mean lactate ± SD (mmol/L) Samples above reference intervala
Single seizure 39 2.0 (1.1-8.4) 2.5 ± 1.6 6 (15.4%)
Cluster seizures 64 1.8 (0.6-7.0) 1.9 ± 0.8 6 (9.4%)
Status epilepticus 12 2.0 (1.2-2.9) 2.0 ± 0.5 2 (16.7%)
Total seizure presentation 115b 1.9 (0.6-8.4) 2.1 ± 1.2 14 (12.2%)
Generalized seizures 93 1.9a (0.6-8.0) 2.0 ± 1.0 8 (8.6%)
Focal seizures 17 2.1b (1.2-8.4) 2.7 ± 1.9 5 (29.4%)
Total seizure semiology 110c 1.9 (0.6-8.4) 2.1 ± 1.2 13 (11.8%)
<24 h 47 1.9 (0.6-7.0) 2.0 ± 1.0 7 (14.9%)
24-72 h 27 1.9 (0.9-8.4) 2.2 ± 1.5 2 (7.4%)
>72 h 40 2.0 (1.2-8.0) 2.2 ± 1.1 5 (12.5%)
Total seizure timing 114d 1.9 (0.6-8.4) 2.1 ± 1.2 14 (12.2%)
1-2 seizures 30 2.0 (0.9-8.4) 2.3 ± 1.5 5 (16.7%)
3-9 seizures 23 1.7 (0.6-2.6) 1.7 ± 0.4 1 (4.3%)
10+ seizures 20 1.9 (1.1-7.0) 2.1 ± 1.3 3 (15%)
Total seizure number 73e 1.9 (0.6-8.4) 2.1 ± 1.2 9 (12.3%)
Note: Within a column, median values with different superscript letters differ significantly (P < .05).
Abbreviation: CSF, cerebrospinal fluid.
aReference interval is 1.0 to 2.5 mmol/L.
bIn 3 dogs, seizure presentation could not be established from the medical record.
cIn 8 dogs, seizure semiology could not be established from the medical record.
dIn 4 dogs, time from last seizure to CSF collection could not be established from the medical record.
eIn 1 dog, the number of seizures could not be established from the medical record.
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found in CSF lactate concentrations among diagnostic groups, with
dogs with presumptive inflammatory and neoplastic disease having
higher concentrations than dogs with idiopathic or unknown epilepsy.
The ROC curve is shown in Figure 2 and indicated that a concentration
exceeding the upper limit of the established lactate reference interval
(0-2.5 mmol/L) was 100% specific in identifying a dog with structural
epilepsy but this concentration had a sensitivity of only 21%.
4 | DISCUSSION
We found a statistically significant difference in CSF lactate concen-
trations between dogs with generalized seizures versus those with
focal seizures, but no differences in lactate concentrations related to
seizure presentation, duration from last seizure to CSF collection, or
number of seizures within the 72 hours preceding CSF collection. Sig-
nificant differences in CSF lactate concentrations were found among
different diagnostic groups, with presumptive neoplastic and inflamma-
tory groups having higher concentrations. Last, a lactate concentration
above the established reference interval (>2.5 mmol/L) was 100%
F IGURE 1 A, Cerebrospinal fluid (CSF) lactate in dogs (n = 114)
grouped by time from last observed seizure to CSF collection. B,
Cerebrospinal fluid lactate in dogs with at least one observed seizure
within 72 hours of CSF collection (n = 73) grouped by number of
observed seizures in this time period. Dogs in status epilepticus were
categorized in the >10 seizure group. Note: Solid lines represent median
values and dotted lines represent the upper limit of the reference interval
TABLE 4 Cerebrospinal fluid lactate concentrations in dogs with seizures
Diagnostic category Number Median lactate (range) (mmol/L) Mean lactate ± SD (mmol/L) Samples above reference interval*
Idiopathic 21 1.6 (1.1-2.4) 1.7 ± 0.3 0 (0%)
Unknown 26 1.7 (0.6-2.5) 1.7 ± 0.4 0 (0%)
Idiopathic/unknown 47 1.7a (0.6-2.5) 1.7 ± 0.4 0 (0%)
Presumptive neoplastic 37 2.0b (0.9-6.1) 2.1 ± 0.8 4 (10.8%)
Presumptive inflammatory 16 2.3b (1.2-8.4) 3.0 ± 2.0 7 (43.8%)
Presumptive vascular 3 2.5 (1.9-2.6) 2.3 ± 0.4 1 (33.3%)
Miscellaneous 12 1.7 (1.1-8.0) 2.3 ± 2.0 2 (16.7%)
Reactive 3 2.1 (1.2-2.2) 1.8 ± 0.6 0 (0%)
All cases 118 1.9 (0.6-8.4) 2.1 ± 1.2 14 (11.8%)
Note: Within a column, median values with different superscript letters differ significantly (P < .05).
*Reference interval is 1.0 to 2.5 mmol/L.
F IGURE 2 Receiver-operating characteristic (ROC) curve
comparing cerebrospinal fluid lactate in dogs with idiopathic/
unknown epilepsy (n = 47) to those with structural epilepsy (n = 68).
The area under the ROC curve is 0.72 (95% confidence
interval = 0.63-0.82)
2566 MARIANI ET AL.
specific for predicting structural epilepsy, albeit with a sensitivity of
only 21%.
In humans, several studies have suggested that CSF lactate con-
centration can be increased after seizures, independent of the under-
lying seizure etiology.9,17-19 This finding has been documented after
both isolated seizures and status epilepticus17,19,26 and occurs in 14% to
28% of patients.18-20,26 Some studies have shown a greater increase in
CSF lactate concentration with status epilepticus when compared with
isolated seizures18,26 or with motor seizures versus nonmotor seizures.20
Other studies have shown less clarity in these areas.17 Similarly, the dura-
tion of seizure activity was a factor in lactate concentration increases in
some studies,26,27 but not in others.17 One report found no difference in
CSF lactate concentrations in children having seizures from various cau-
ses compared with controls, but discovered that a higher proportion of
those with recurrent or prolonged seizures (>30 minutes) had increased
lactate concentrations.28,29 Another study found that increases in CSF
lactate concentrations were more likely associated with a shorter latency
from status epilepticus to CSF collection19 and a number of reports have
documented increased CSF lactate concentration for up to 72 hours after
seizure events.9,26,27 Recommendations for normative CSF lactate data
on humans suggest excluding patients with refractory epilepsy or those
having recent seizures (within 24 hours).30
We could not find evidence to support a role for seizure activity
causing an increase in CSF lactate concentration in our study. In fact,
somewhat counterintuitively, dogs with focal seizures had higher lac-
tate concentrations than did those with generalized seizures in this
cohort. In addition, no difference was found in lactate concentrations
between dogs with single seizures and those with cluster seizures or
status epilepticus and no evidence was found that recent seizures
were more likely to be associated with a higher CSF lactate concen-
tration than those with a longer interval between the seizure event
and CSF collection. It is possible the CSF lactate was higher in animals
with focal seizures because dogs with structural epilepsy were more
likely to have focal seizures (i.e., that the lactate differences were
driven primarily by the disease process and not the nature of the sei-
zures). After eliminating those dogs in which seizure semiology was
undetermined, 6/46 (13.0%) idiopathic or unknown cases and 11/61
(18.0%) structural cases had focal seizures. However, these data on
seizure semiology must be viewed cautiously because the differences
in lactate concentration are relatively small, and we considered dogs
with both focal and generalized seizures in the generalized category in
the analysis of seizure semiology. In addition, it is very difficult to dis-
tinguish dogs that have a focal onset of their seizures with rapid sec-
ondary generalization from those having true generalized seizures,
particularly in a retrospective study relying mainly on owner-reported
events. We suspect that this finding has no clinical relevance, but it
should perhaps be further investigated in future studies.
Limited published information is available regarding CSF lactate
concentrations in dogs with seizures, and we are not aware of other
clinical studies investigating them in veterinary patients. Experimental
studies in various species, including dogs, have shown that prolonged
seizures lead to increased cerebral blood flow and an increase in cere-
bral consumption of oxygen and glucose that is 2 to 3 times normal
throughout sustained seizure activity.31-33 Concurrently, a number of
studies have shown increases in brain tissue lactate concentrations
with experimental seizure activity.31,34-36 The conclusion of many of
these studies is that the mechanism of increased CSF lactate concen-
tration with seizure activity is related to increased metabolic activity
resulting from intense and coordinated neuronal firing and not to the
presence of hypoxic conditions.31,32,36,37 Instead, it is thought that glu-
cose is diverted from mitochondrial oxidative degradation and instead
is shunted to anaerobic glycolysis pathways, with large amounts of lac-
tate being released into the brain parenchyma and potentially into the
CSF.32,38,39
However, an experimental study of dogs induced to have seizures
using IV pentylenetetrazol or an electroconvulsive instrument showed
that brain tissue and CSF lactate concentrations remain unaffected in
dogs having seizures when anesthetized and ventilated on 100% oxy-
gen.40 In dogs allowed to become hypoxemic (PaO2 of 21-48 mm Hg),
brain tissue lactate concentration increased (approximately 2-fold)
whereas CSF lactate concentration showed no changes.40 Notably,
these CSF measurements were made during seizure activity and
changes in brain lactate concentration may not have had time to be
reflected in the CSF. Nonanesthetized dogs having spontaneous sei-
zures are likely to have blood oxygen tensions that fall between those
reported in the 2 groups in this experimental study. A previous study
showed a modest increase in mean CSF lactate concentration (3.8 mmol/L
from a baseline of 3.1 mmol/L) when sampled immediately after 8 chemi-
cally induced seizures in anesthetized dogs ventilated with 100% oxygen.33
A study of experimentally induced seizures in rats showed that CSF lactate
concentration was increased as early as 10 minutes after administration of
a proconvulsant compound, but had returned to normal by 6 hours after
seizures.41
The reason for a lack of increased CSF lactate concentration in the
dogs without structural epilepsy in our study is unclear. Discrepancies
in experimental methods, species evaluated, anesthetic protocols, arte-
rial oxygen saturation, methods of seizure induction, duration of seizure
activity, and number of seizures make comparison among experimental
studies challenging. However, the available data suggest that any
increase in CSF lactate concentration in dogs with normal to increased
arterial oxygen tensions is modest at best and may be transient. Unlike
the scenario for most humans, CSF collection in clinical canine patients
is performed under general anesthesia, typically in scenarios with
increased oxygen tension in the blood. Therefore, if hypoxemia is a
contributory factor in the development of increased brain and poten-
tially CSF lactate concentrations, as suggested previously,40 this change
may have been masked by the anesthetic protocol, because dogs in our
study were maintained on isoflurane or sevoflurane in oxygen and CSF
was collected after brain imaging, potentially allowing additional time for
normalization of lactate concentrations. Because CSF from dogs invari-
ably is collected under general anesthesia and oxygen supplementation,
increased blood oxygen concentrations may abrogate some of the poten-
tial effects of seizures on CSF lactate concentrations in clinical canine
patients.
Other mechanisms aside from relative oxygen debt have been
advanced to explain increased lactate production during seizures.
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Excess synaptic glutamate associated with excessive neuronal fir-
ing is taken up by astrocytes, and stimulates glycolytic activity in
astrocytes and subsequent release of lactate into the extracellular
space.41,42 In addition, although somewhat controversial, evidence
now suggests that lactate can be used as a fuel source for neu-
rons.38,39 Relative differences in brain volume, the number of neu-
rons and supporting cells involved in the seizure and the
mechanisms of seizure initiation or propagation between dogs and
humans all may play a role in explaining the discrepancies noted in
CSF lactate concentration between dogs and human patients.
Many of the studies in humans described above excluded patients
with infectious or inflammatory meningoencephalitis or meningeal
carcinomatosis but included patients with solitary brain tumors, cere-
brovascular accidents, and other forms of structural epilepsy.18-20
Several of these studies failed to detect differences in CSF lactate
concentrations when comparing patients with structural (symptom-
atic) epilepsy to those with unknown (cryptogenic) epilepsy.20,26 How-
ever, similar to our study, 2 previous studies found higher CSF lactate
concentrations in human patients with structural epilepsy.18,19 Ulti-
mately, CSF lactate concentrations in dogs with seizure activity may
depend on the oxygenation state of the dog in question, additional
comorbidities, and the underlying etiology initiating seizure activity.
Our study had several limitations. Although most of the CSF sam-
ples in our study were collected and analyzed prospectively, medical
records were reviewed retrospectively, which contributed to some
incomplete information with respect to seizure presentation, timing,
and semiology. Samples from both the cerebellomedullary cistern and
lumbar subarachnoid space were used, and the effect of sampling site
on lactate concentration is unknown. It is possible that CSF lactate
concentration changes secondary to seizures are diminished in sam-
ples collected from the lumbar subarachnoid space because of the rel-
ative distance of this collection site from the brain. One study
comparing clinically healthy dogs found higher lactate concentrations
in CSF collected from the lumbar subarachnoid space compared to
the cerebellomedullary cistern, suggesting concentration of this ana-
lyte with caudal flow of CSF, although the difference was small
(means of 1.58 mmol/L and 1.44 mmol/L respectively).43 The number
of samples collected from the lumbar region in our study was small
(8/110) and of these, 3/8 (0/1 idiopathic, 1/3 neoplastic, 1/3 inflam-
matory, and 1/1 miscellaneous) had lactate concentrations above the
reference interval. We therefore suspect that the site of collection
had little influence on the results and conclusions of our study,
although this possibility might be worthy of future investigation. We
did not exclude cases based on blood contamination of CSF, which
may have led to alterations of CSF lactate concentrations in some
cases. However, we found no correlation between CSF red blood cell
counts and CSF lactate concentrations. In the entire cohort of 118 dogs,
only 13 dogs had a CSF RBC count > 500/μL, and of these 2/13
(15.4%) had CSF lactate concentrations that exceeded the high end of
the reference interval. We did not consistently measure matched blood
lactate concentrations in these dogs and cannot more rigorously inves-
tigate this relationship. However, it appears unlikely that blood contam-
ination spuriously increased CSF lactate concentrations in our study
although falsely decreased lactate concentrations from a dilutional
effect are possible.
We used clinical presentation, examination results, blood tests,
neuroimaging findings, results of CSF analysis and response to treat-
ment to categorize dogs into diagnostic groups, and it is possible that
diagnoses in some dogs were incorrect. In addition, seizures them-
selves can create imaging abnormalities within the brain that are tran-
sient in nature,44-46 which also may have complicated diagnostic
accuracy in our study. Although such postictal changes could be con-
fused with several etiologies, such as neoplastic disorders or cerebro-
vascular disease, the primary concern is with meningoencephalitis. In
these previous studies, the results of CSF analysis have been unremarkable
or have shown albuminocytologic dissociation. Few dogs in our study had
repeat brain imaging to better define any potential transient nature or
improvement of the lesions noted. Of the 16 dogs diagnosed with pre-
sumptive inflammatory CNS disease, only 2 had normal CSF nucleated cell
counts, and 1 of these was diagnosed with distemper encephalitis after
necropsy examination. Of the 3 dogs diagnosed with cerebrovascular disor-
ders in our study, 1 had what appeared to be an old thalamic infarct and
2 had lesions consistent with hemorrhagic infarcts, findings that are not
typical of what has been reported for transient post-ictal changes in dogs.
In the dogs categorized with miscellaneous structural lesions, most had
MRI abnormalities that were also inconsistent with described transient
post-ictal changes (Table S1). However, 2 dogs had MRI and CSF findings
that could represent such changes, although both had normal CSF lactate
concentrations. Thus, we suspect few dogs in our cohort had lesions solely
attributable to their seizures, and some incorrect diagnoses, although possi-
ble, should not substantially change the main conclusions of our study.
Finally, the CSF lactate concentration reference interval used was devel-
oped using dogs without identifiable CNS pathology, and in part using dogs
with idiopathic and unknown epilepsy, because CSF from clinically normal
dogs was not available for that study.4 Although dogs having seizures
within 24 hours of CSF collection were eliminated in development of these
variables, it is possible that dogs with refractory idiopathic or unknown epi-
lepsy could have CSF lactate concentrations that are truly increased com-
pared to clinically normal dogs, and future adjustment of this reference
interval might be indicated. However, we found no effect of proximity of
seizures to CSF collection on CSF lactate concentration in our study.
Regardless, our study indicates that a CSF lactate concentration exceeding
the current reference interval (>2.5 mmol/L) is highly predictive for struc-
tural epilepsy.
In conclusion, seizures appear to have minimal effect on lactate
concentration in CSF obtained by conventional methods, and
increased CSF lactate concentrations in dogs presenting with sei-
zures are more likely related to the underlying disease process. Find-
ing a CSF lactate concentration above the current reference interval
(>2.5 mmol/L) may be a useful, rapid way to identify dogs at risk for
structural epilepsy.
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